VERV
VERVE THERAPEUTICS INC
๐บ๐ธ NYSE/NASDAQ
๐ Overview
๐ Performance
๐ต Cost
๐ Esg
๐ค Advanced
๐จโ๐ฉโ๐งโ๐ฆ Community
๐
-22.94%
Annual Growth
3 years average annual growth
๐
1
Pearlers Invested
Since January 2020
๐ Overview
Key information
๐ Fund Overview
Verve Therapeutics, Inc. is a clinical-stage genetic medicines company. The Company is focused on developing a new approach to the care of cardiovascular disease (CVD), transforming treatment from chronic management to single-course gene editing medicines. The Companyโs lead programs include VERVE-101, VERVE-102, and VERVE-201, which target genes that have been validated as targets for lowering low-density lipoprotein cholesterol (LDL-C), a root cause of atherosclerotic cardiovascular disease (ASCVD). VERVE-101 and VERVE-102 are designed to permanently turn off the PCSK9 gene in the liver and are being developed initially for heterozygous familial hypercholesterolemia (HeFH). VERVE-201 is designed to permanently turn off the ANGPTL3 gene in the liver and is initially being developed for homozygous familial hypercholesterolemia (HoFH) and for refractory hypercholesterolemia where patients still have high LDL-C despite treatment with maximally tolerated standard of care therapies.
๐ Performance
Price History*
-79.71%
1M
1Y
All Time
Graph
Table
* US price history does not take into account stock splits
Unsure how much or often to invest?
๐๏ธ Investing frequency calculator
Determine the investment frequency needed to reach your goals
Try it out โ๐ต Investing amount calculator
Determine the recurring investment needed to reach your goals
Try it out โโฑ๏ธ Investing duration calculator
Determine how long you will need to invest to reach your goals
Try it out โ๐ต Costs
๐ผ
N/A
Management Fee
Included in unit price, not charged by Pearler
๐ธ
Want to know the long term costs?
Calculate the historic long term costs to hold your investments
๐ธ Net fee calculator๐ค Advanced information
Technical Info
๐ฐ Price*
$6.47
*Price may be up to 24 hours old
๐ฉโ๐ฉโ๐ฆ Community Insights
How our community is investing
๐ Pearlers invested in VERV
1
๐ Total Capital Earnings
N/A
๐ Average investment frequency
109 weeks
๐ต Average investment amount
$13,668
โฐ Last time a customer invested in VERV
66 days
VERV investor breakdown
๐ต Income of investors
More than 200k
150k - 200k
100k - 150k
50k - 100k
100%
Less than 50k
๐ถ Age of investors
18 - 25
26 - 34
100%
35 - 90
๐ Legal gender of investors
Female
Male
100%
Pearlers who invest in VERV also invest in...
๐ Performance (5Yr p.a)
39.20%
๐ Share price
$165.43 USD
๐ HIGH PRICE GROWTH
๐ Performance (5Yr p.a)
34.87%
๐ Share price
$644.54 USD
๐ HIGH PRICE GROWTH
๐ Performance (5Yr p.a)
30.02%
๐ Share price
$352.70 USD
๐ HIGH PRICE GROWTH
Want more shares? Try these...